Literature DB >> 734357

Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.

S Becker, U Hadding, H U Schorlemmer, D Bitter-Suermann.   

Abstract

3H-serotonin release from guinea-pig platelets was demonstrated to be the consequence of C3a binding to these cells. A Scatchard analysis of dose-response data of the 125I-C3a binding pattern to guinea-pig platelets pointed to the existence of binding sites with high and low affinity for the C3a molecule (HA and LA receptors). HA receptors are specific for C3a with intact C-terminal arginine. whereas C3adesarg only interacts with LA receptors. The release of serotonin may be induced by a combined reaction of C3a with HA receptors and LA receptors on the platelet membrane.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 734357     DOI: 10.1111/j.1365-3083.1978.tb00555.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

Review 1.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

2.  Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.

Authors:  S Meuer; T E Hugli; R H Andreatta; U Hadding; D Bitter-Suermann
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

3.  In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.

Authors:  T Hoffmann; E C Böttger; H P Baum; M Messner; U Hadding; D Bitter-Suermann
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Alternative Complement Pathway Activation Provokes a Hypercoagulable State with Diminished Fibrinolysis.

Authors:  Jason M Samuels; Julia R Coleman; Ernest E Moore; Matt Bartley; Navin Vigneshwar; Mitchell Cohen; Christopher C Silliman; Angela Sauaia; Anirban Banerjee
Journal:  Shock       Date:  2020-05       Impact factor: 3.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.